SCLX Stock Summary and Trading Ideas (Scilex Holding Company | NASDAQ:SCLX)

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Scilex Holding Company trades on the NASDAQ stock market under the symbol SCLX.

As of December 19, 2025, SCLX stock price declined to $14.35 with 56,342 million shares trading.

SCLX has a beta of -0.11, meaning it tends to be less sensitive to market movements. SCLX has a correlation of 0.00 to the broad based SPY ETF.

SCLX has a market cap of $100.92 million. This is considered a Micro Cap stock.

Last quarter Scilex Holding Company reported $11 million in Revenue and -$22.17 earnings per share. This fell short of revenue expectation by $-37 million and missed earnings estimates by -$22.24.

In the last 3 years, SCLX traded as high as $591.51 and as low as $3.60.

The top ETF exchange traded funds that SCLX belongs to (by Net Assets): VTI, VXF, ITOT, IWC, URTY.

SCLX has underperformed the market in the last year with a price return of -6.9% while the SPY ETF gained +18.1%. SCLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -50.7% and -25.1%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

SCLX support price is $13.58 and resistance is $15.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCLX shares will trade within this expected range on the day.